The drug from the common cold :: Consumers survey results of 2011

Consumers survey results of 2011 in category

Cold and Flu / The drug from the common cold

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Піносол (Zentiva)	41.94%	5

2.		Назол (Bayer)	26.34%	2.96

3.	6	Nasivin (Dr. Reddy’s)	22.04%	2.47

4.	3	Нокспрей (Сперко Україна)	22.04%	2.43

5.	12	Санорин (Teva)	15.05%	1.84

6.	11	Aqua Maris (Jadran)	15.59%	1.71

7.	5	Синупрет (Bionorica)	13.98%	1.66

8.	10	Віброцил (Novartis OTC)	14.52%	1.59

9.	14	Нафтизин (Farmak)	10.75%	1.34

9.	17	Риназолін (Farmak)	11.29%	1.34

11.	7	Делуфен (Perrigo)	11.29%	1.29

12.	13	Фармазолін (Farmak)	11.29%	1.17

13.	15	Евказолін Аква (Farmak)	9.68%	1.16

14.	27	Длянос (Novartis OTC)	8.60%	0.99

15.	8	Спрей назальний др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	7.53%	0.88

16.	25	Но-соль (Farmak)	6.45%	0.67

17.	21	Отривін (Novartis OTC)	5.91%	0.65

18.		Салін (Bayer)	5.91%	0.62

19.	9	Мілістан Сінус (Mili Healthcare)	4.84%	0.58

20.		Tyzine (Johnson & Johnson)	4.84%	0.53

21.		Цинабсин (DHU)	4.30%	0.52

22.	14	Галазолін (ICN Polfa Rzeszow)	3.76%	0.48

23.	26	Асініс (Perrigo)	3.23%	0.40

24.	16	Назалонг (Валартін Фарма)	3.76%	0.38

25.	27	Ксилогексал (Sandoz)	2.69%	0.35

26.	23	Назолін-Дарниця (Darnitsa)	2.69%	0.34

27.	19	Каметон (Стома)	2.69%	0.31

28.	~	Аллертек (ICN Polfa Rzeszow)	1.61%	0.20

29.	4	Актифед (GlaxoSmithKline)	1.61%	0.17

30.	22	Трайфед (Hikma)	1.08%	0.16

31.	24	Гайморин (Національна гомеопатична спілка)	1.61%	0.13

31.	28	Піновіт (Farmak)	1.61%	0.13

33.	29	Риностоп (Bosnalijek)	1.08%	0.12

34.	26	Ріназал (Darnitsa)	1.08%	0.09

35.	30	Грипостад Ріно (Nizhpharm)	0.54%	0.08

35.	27	Ксилометазолін (ICN Polfa Rzeszow)	0.54%	0.08

35.	~	Ноксивін (Фармтехнологія)	0.54%	0.08

35.	~	СНУП (Stada)	0.54%	0.08

39.	~	Орінол плюс (Bayer)	0.54%	0.04

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2011, recommendation of consumers #1 in the category “The drug from the common cold”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2011, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.